ArticleGenes2022
Old and New Systemic Immune-Inflammation Indexes Are Associated with Overall Survival of Glioblastoma Patients Treated with Radio-Chemotherapy.
Open access · goldAbstract read
In one paragraph
Article in Genes, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 2 of them syntheses that pooled it.
0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 2 pooled it
2.1field-weighted citation impact, top 11% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 2 syntheses or guidelines pooled it, 21 citations in OpenAlex.
- The role of preoperative thrombocytic factors on survival in patients with glioblastoma: a meta-analysis and synopsis of the literature.Neurosurgical review · 2026Pooled it
- Prognostic role of the pretreatment systemic immune-inflammation index in patients with glioma: A meta-analysis.Frontiers in neurology · 2023Pooled it
- Comparative Longitudinal Evaluation of Systemic Inflammatory Markers in Type 2 Diabetes Treated with Four Oral Antidiabetic Drug Classes.Journal of clinical medicine · 2026Article
- Prognostic relationship of peripheral blood-immune inflammatory index (C-PLAN) in patients with high-grade glioma.BMC cancer · 2025Article
- Liquid biopsy in breast cancer: Redefining precision medicine.The journal of liquid biopsy · 2025Review
- Systemic inflammatory markers and volume of enhancing tissue on post-contrast T1w MRI images in differentiating true tumor progression from pseudoprogression in high-grade glioma.Clinical and translational radiation oncology · 2024Article
- Heterogeneity and individualized treatment of microenvironment in glioblastoma (Review).Oncology reports · 2023Article
- Forkhead box transcription factors (FOXOs and FOXM1) in glioma: from molecular mechanisms to therapeutics.Cancer cell international · 2023Review
- Cell-Free miRNAs as Non-Invasive Biomarkers in Brain Tumors.Diagnostics (Basel, Switzerland) · 2023Review
- Immuno markers in newly diagnosed glioblastoma patients underwent Stupp protocol after neurosurgery: a retrospective series.Journal of neuro-oncology · 2023Article
- Prognostic Values of Systemic Inflammatory Immunological Markers in Glioblastoma: A Systematic Review and Meta-Analysis.Cancers · 2023Review
- Article
- Macrophages in Recurrent Glioblastoma as a Prognostic Factor in the Synergistic System of the Tumor Microenvironment.Neurology international · 2023Review
- Transcriptomic Establishment of Pig Macrophage Polarization Signatures.Current issues in molecular biology · 2023Article
- Article
- Upstaging and Downstaging in Gliomas-Clinical Implications for the Fifth Edition of the World Health Organization Classification of Tumors of the Central Nervous System.Diagnostics (Basel, Switzerland) · 2023Article
- Prognostic Value of Systemic Immune-Inflammation Index (SII) in Patients with Glioblastoma: A Comprehensive Study Based on Meta-Analysis and Retrospective Single-Center Analysis.Journal of clinical medicine · 2022Article
- Multiparametric Longitudinal Profiling of RCAS-tva-Induced PDGFB-Driven Experimental Glioma.Brain sciences · 2022Article
- Article
- A Novel Necroptosis-Related Prognostic Signature of Glioblastoma Based on Transcriptomics Analysis and Single Cell Sequencing Analysis.Brain sciences · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
21 authors at 3 institutions in 2 countries.
Francesco PasqualettiRadiation Oncology Unit, Azienda Ospedaliero Universitaria Pisana, 56124 Pisa, Italy.ORCID 0000-0002-0788-1205
Celeste GiampietroUO Laboratorio Analisi Chimico Cliniche, Azienda Ospedaliero Universitaria Pisana, 56124 Pisa, Italy.
Nicola MontemurroNeurosurgery Unit, Azienda Ospedaliero Universitaria Pisana, 56124 Pisa, Italy.ORCID 0000-0002-3686-8907
Noemi GianniniRadiation Oncology Unit, Azienda Ospedaliero Universitaria Pisana, 56124 Pisa, Italy.
Giovanni GadducciRadiation Oncology Unit, Azienda Ospedaliero Universitaria Pisana, 56124 Pisa, Italy.
Paola OrlandiDepartment of Clinical and Experimental Medicine, University of Pisa, 56126 Pisa, Italy.
Eleonora NataliUO Laboratorio Analisi Chimico Cliniche, Azienda Ospedaliero Universitaria Pisana, 56124 Pisa, Italy.ORCID 0000-0003-2237-3871
Paolo ChiarugiUO Laboratorio Analisi Chimico Cliniche, Azienda Ospedaliero Universitaria Pisana, 56124 Pisa, Italy.
Alessandra GonnelliRadiation Oncology Unit, Azienda Ospedaliero Universitaria Pisana, 56124 Pisa, Italy.ORCID 0000-0002-4087-1949
Martina CantarellaRadiation Oncology Unit, Azienda Ospedaliero Universitaria Pisana, 56124 Pisa, Italy.ORCID 0000-0003-1106-3595
Cristian ScatenaDepartment of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, 56126 Pisa, Italy.ORCID 0000-0002-4862-0845
Giuseppe Nicolò FanelliDepartment of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, 56126 Pisa, Italy.ORCID 0000-0001-7069-7980
Antonio Giuseppe NaccaratoDepartment of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, 56126 Pisa, Italy.ORCID 0000-0002-8195-9445
Paolo PerriniNeurosurgery Unit, Azienda Ospedaliero Universitaria Pisana, 56124 Pisa, Italy.ORCID 0000-0002-3251-6111
Gaetano LibertiNeurosurgery Unit, Azienda Ospedaliero Universitaria Pisana, 56124 Pisa, Italy.
Riccardo MorgantiDepartment of Statistics, University of Pisa, 56126 Pisa, Italy.ORCID 0000-0001-7783-0262
Maria FranziniDepartment of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, 56126 Pisa, Italy.ORCID 0000-0001-9496-9370
Aldo PaolicchiDepartment of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, 56126 Pisa, Italy.
Giovanni PellegriniUO Laboratorio Analisi Chimico Cliniche, Azienda Ospedaliero Universitaria Pisana, 56124 Pisa, Italy.ORCID 0000-0003-3131-1605
Guido BocciDepartment of Clinical and Experimental Medicine, University of Pisa, 56126 Pisa, Italy.ORCID 0000-0001-7120-9141
Fabiola PaiarRadiation Oncology Unit, Azienda Ospedaliero Universitaria Pisana, 56124 Pisa, Italy.
Azienda Ospedaliera Universitaria Pisana · ITUniversity of Pisa · ITUniversity of Oxford · GB
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
GlioblastomaAdultAgedAged, 80 and overFemaleHumansInflammationLymphocytesMaleMiddle AgedNeutrophilsPrognosisglioblastomainflammation indexNPM/LNPW/LMSIIsystemic immune-inflammation index
Identifiers
What Socratic holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.